Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1980
mi
from 43215
Inglewood, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1980
mi
from 43215
Inglewood, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1926
mi
from 43215
La Jolla, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1926
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
2062
mi
from 43215
Santa Maria, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
2062
mi
from 43215
Santa Maria, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1958
mi
from 43215
Tustin, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1958
mi
from 43215
Tustin, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1939
mi
from 43215
Upland, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1939
mi
from 43215
Upland, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1911
mi
from 43215
Victorville, CA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1911
mi
from 43215
Victorville, CA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
874
mi
from 43215
Sarasota, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
874
mi
from 43215
Sarasota, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
866
mi
from 43215
Sebring, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
866
mi
from 43215
Sebring, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
353
mi
from 43215
Springfield, IL
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
353
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
300
mi
from 43215
Frederick, MD
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
300
mi
from 43215
Frederick, MD
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
206
mi
from 43215
Lansing, MI
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
206
mi
from 43215
Lansing, MI
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
174
mi
from 43215
St. Clair Shores, MI
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
174
mi
from 43215
St. Clair Shores, MI
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
136
mi
from 43215
Mayfield Village, OH
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
136
mi
from 43215
Mayfield Village, OH
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
212
mi
from 43215
Erie, PA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
212
mi
from 43215
Erie, PA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
351
mi
from 43215
Greer, SC
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
351
mi
from 43215
Greer, SC
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated:  2/18/2016
970
mi
from 43215
Winnipeg,
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status: Enrolling
Updated: 2/18/2016
970
mi
from 43215
Winnipeg,
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Coon Joint Replacement Institue; St. Helena Hospital
2096
mi
from 43215
St. Helena, CA
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Coon Joint Replacement Institue; St. Helena Hospital
2096
mi
from 43215
St. Helena, CA
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Florida Orthopedic Institute
831
mi
from 43215
Tampa, FL
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Florida Orthopedic Institute
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated:  2/18/2016
Memorial Bone and Joint Research Foundation; Memorial Hermann Memorial City Medical Center
991
mi
from 43215
Houston, TX
Robotic Arm Assisted Total Knee Arthroplasty
Robotic Arm Assisted Total Knee Arthroplasty
Status: Enrolling
Updated: 2/18/2016
Memorial Bone and Joint Research Foundation; Memorial Hermann Memorial City Medical Center
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Yale University
537
mi
from 43215
New Haven, CT
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
The Feinstein Institute for Medical Research
494
mi
from 43215
Manhasset, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
The Feinstein Institute for Medical Research
494
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
University of Rochester
354
mi
from 43215
Rochester, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Oklahoma Medical Research Foundation
848
mi
from 43215
Oklahoma City, OK
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Oklahoma Medical Research Foundation
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
910
mi
from 43215
Dallas, TX
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Emory University
435
mi
from 43215
Atlanta, GA
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
150
mi
from 43215
Clarksburg, WV
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
150
mi
from 43215
Clarksburg, WV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
462
mi
from 43215
Anniston, AL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
462
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
1666
mi
from 43215
Peoria, AZ
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
1666
mi
from 43215
Peoria, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
1939
mi
from 43215
Upland, CA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
1939
mi
from 43215
Upland, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
745
mi
from 43215
Ormond Beach, FL
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
745
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
154
mi
from 43215
Lexington, KY
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
206
mi
from 43215
Kalamazoo, MI
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
206
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
660
mi
from 43215
Flowood, MS
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
660
mi
from 43215
Flowood, MS
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
1938
mi
from 43215
Reno, NV
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
1938
mi
from 43215
Reno, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
527
mi
from 43215
Charleston, SC
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  3/1/2016
5106
mi
from 43215
Sofia,
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 3/1/2016
5106
mi
from 43215
Sofia,
Click here to add this to my saved trials